It has been one year since President Trump was sworn in for a second time. Bspoke Investment Group assembled the ETF asset class matrix below, showing returns in the asset classes since inauguration.

Several Indian companies are preparing to launch generic versions of GLP-1 category drug Semaglutide in India ...

LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost ‌to rival Eli Lilly. Booming ...

Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album sales. Starting in January, the magazine and authoritative record of music ...

The change is being implemented to reflect an increase in streaming revenue, along with changing music consumption behaviors. By Billboard Staff Starting in January, the Billboard charts will add more ...

Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its "Metabolic Frontier 2030" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the firm to become Europe's most ...